Medicine and Dentistry
Pediatrics
100%
Kidney Transplantation
62%
Hemodialysis
62%
Pediatrics Patient
51%
Kidney Function
47%
Prevalence
39%
Urinary Tract Infection
32%
Proteinuria
31%
Kidney Graft
28%
Diseases
25%
Acute Kidney Injury
25%
Burosumab
25%
X Linked Hypophosphatemic Rickets
25%
Glomerular Filtration Rate
23%
Elevated Blood Pressure
18%
Nephrotic Syndrome
18%
Vesicoureteral Reflux
16%
Focal Segmental Glomerulosclerosis
15%
Urinary Tract
14%
Retrospective Study
14%
End Stage Renal Disease
14%
Nephrocalcinosis
14%
Neoplasm
14%
Chronic Kidney Disease
14%
Intermittent Catheterisation
13%
Neonate
13%
Blood Pressure
13%
Creatinine
13%
Tubular Dysfunction
12%
Kidney Injury
12%
Vascular Access
12%
Escherichia coli
11%
Renal Failure
11%
Rickets
11%
Survival Rate
11%
Nephritic Syndrome
10%
Cardiovascular System
10%
Prematurity
10%
Radioisotope Renography
10%
Lymphoproliferative Disease
10%
Graft Survival
10%
Cardiovascular Risk
10%
Fibroblast Growth Factor 23
10%
Congenital Nephrotic Syndrome
10%
Neurogenic Bladder
9%
Asymptomatic Bacteriuria
9%
Graft Failure
9%
Congenital Malformation
9%
Cesarean Section
9%
Hypercalciuria
8%
Keyphrases
Pediatric Patients
51%
Transplantation
38%
Pediatric
38%
Hemodialysis
36%
Kidney
35%
Burosumab
34%
Dialysis
32%
Kidney Transplantation
28%
X-linked Hypophosphatemia
25%
Pretransplant
25%
Urinary Tract Infection
24%
Renal Transplantation
22%
Nephrotic Syndrome
21%
Acute Renal Failure
20%
Pediatric Kidney Transplantation
19%
Pediatric Dialysis
19%
Steroid-resistant Nephrotic Syndrome
18%
Hypertension
18%
Elevated Blood Pressure
18%
PLCE1
18%
Single-center Experience
17%
Brown Recluse Spider Bite
17%
Hemodialysis Patients
15%
Vesicoureteral Reflux
15%
Kidney Function
14%
Focal Segmental Glomerulosclerosis
14%
Dialysis Facility
14%
Nephrocalcinosis
14%
Clean Intermittent Catheterization
14%
Rickets
13%
Neonate
13%
Renal Function
13%
Blood Pressure
13%
Kidney Transplant Recipients
12%
Vascular Access
12%
Proteinuria
11%
Rare Complication
11%
End-stage Renal Disease
11%
Diffuse Mesangial Sclerosis
11%
Treatment Outcome
11%
High Prevalence
11%
Urinary Tract
10%
Chronic Kidney Disease
10%
Linear Growth
10%
Cardiovascular Risk
10%
Truncating mutation
10%
Solid Organ Transplantation
10%
Clinical Presentation
10%
Neurogenic Bladder
10%
Functional Analysis
10%